Prozac may help to curb disease activity in multiple sclerosis

The antidepressant Prozac may help to curb disease activity in the relapsing remitting form of multiple sclerosis (MS), reveals preliminary research published ahead of print in the Journal of Neurology Neurosurgery and Psychiatry.

If you want to include this story in your blog, copy and paste this formatted text: